XOMA Royalty Corporation (XOMAP NASDAQ) stock market data APIs
$25.5761
-0.05(-0.2%)
as of May 20, 2026
Try our APIs with
free plan!
XOMA Royalty Corporation Financial Data Overview
Price chart is built with
Anychart
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers; and acquires milestone and royalty revenue streams on late-stage clinical assets and commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
Prev. Close
25.5761
Open
25.529
High
25.6377
Low
25.5
52 wk Range
23.407-28.2216
Market Cap
0
P/E Ratio
25.2747
Revenue
48 555 K
EPS
0.7
Dividends (Yield)
0
Beta
0.902
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get XOMA Royalty Corporation data using free add-ons & libraries
Get XOMA Royalty Corporation Fundamental Data
XOMA Royalty Corporation Fundamental data includes:
- Net Revenue: 48 555 K
- EBITDA: 8 295 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get XOMA Royalty Corporation Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2025-11-12
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
XOMA Royalty Corporation News
New
Royalty Powerhouse: Ligand And Xoma Unite In $739 Million Deal
Ligand Pharmaceuticals snatched up Xoma Royalty in a deal worth $739 million, the companies said Monday as both biotech stocks jumped. Continue Reading
Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator
Ligand Pharmaceuticals Transaction expands Ligand’s royalty portfolio to more than 200 assets and adds seven new commercial products Bolsters and diversifies Ligand’s long-term compounding growt...
XOMA Royalty Q4 Earnings Call Highlights
XOMA Royalty logo Key Points XOMA called 2025 a “foundational year,” adding 22 assets and reporting total portfolio receipts of more than $50 million, including $34 million of royalties (up 68% ...
XOMA Preferred Shares Series A declares $0.5391 dividend
* XOMA Preferred Shares Series A (XOMAP [https://seekingalpha.com/symbol/XOMAP]) declares $0.5391/share quarterly dividend [https://seekingalpha.com/pr/20443664-xoma-royalty-declares-quarterly-prefe...
Get XOMA Royalty Corporation fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
